NFA
FLXN

Nationwide Fund Advisors’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Nationwide Fund Advisors’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-40,280
Closed -$974K – 2531
2017
Q3 		$974K Hold
40,280
– – ﹤0.01% 1798
2017
Q2 		$814K Buy
40,280
+8,026
+25% +$167K ﹤0.01% 1902
2017
Q1 		$868K Sell
32,254
-600
-2% -$12.3K ﹤0.01% 1848
2016
Q4 		$625K Sell
32,854
-181
-0.5% -$3.46K ﹤0.01% 2050
2016
Q3 		$646K Buy
33,035
+3,940
+14% +$66.6K ﹤0.01% 2041
2016
Q2 		$435K Buy
29,095
+3,660
+14% +$46K ﹤0.01% 2225
2016
Q1 		$234K Buy
25,435
+507
+2% +$6.15K ﹤0.01% 2464
2015
Q4 		$480K Hold
24,928
– – ﹤0.01% 2137
2015
Q3 		$370K Buy
24,928
+11,680
+88% +$274K ﹤0.01% 2269
2015
Q2 		$290K Buy
13,248
+8,777
+196% +$177K ﹤0.01% 2523
2015
Q1 		$101K Buy
4,471
+175
+4% +$4.05K ﹤0.01% 2958
2014
Q4 		$87K Buy
4,296
+740
+21% +$13.4K ﹤0.01% 2939
2014
Q3 		$65K Sell
3,556
-6,200
-64% -$89.8K ﹤0.01% 3073
2014
Q2 		$132K Sell
9,756
-9,931
-50% -$135K ﹤0.01% 2934
2014
Q1 		$324K Buy
+19,687
New +$340K ﹤0.01% 2266

Other funds holding FLXN

GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Nationwide Fund Advisors's FLXN Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2017, closing a stake of 40,280 shares — an estimated $974K sold.

Nationwide Fund Advisors first reported a position in FLXN in Q1 2014 and held it in 15 quarters. The position peaked at $974K in Q3 2017. 139 funds tracked by Wall St. Rank hold FLXN as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Flexion Therapeutics, Inc. position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 40,280 Flexion Therapeutics, Inc. shares in Q4 2017, an estimated $974K.
  • Nationwide Fund Advisors first reported a position in Flexion Therapeutics, Inc. in Q1 2014 and held it in 15 quarters.
  • Nationwide Fund Advisors's Flexion Therapeutics, Inc. position peaked at $974K in Q3 2017.
  • 139 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.